News › Industry News, Patient Care

US FDA Pushes Sunscreen Reform on Three Fronts

June 20, 2018

The U.S. Food and Drug Administ­ration (FDA) has announced three new efforts to advance its framework for sun protection products: 1) ensuring accurately promoted/marketed sunscreen benefits; 2) supporting safer and more effective sunscreen innovations, now with Maximal Usage Trials (MUsT); and 3) enforcement guidance for the OTC topicals industry. These efforts are being set forth now, before North American consumers head into the summer sun, and in line with the #DontFryDay sunscreen advocacy drive.
According to an FDA statement issued by Scott Gottlieb, M.D., FDA Commissioner, “Consumers should know the products they are using to protect themselves are effective at guarding against harmful UV radiation and safe to use on themselves and their families. Unfortun­ately, this isn’t always the case. 
Read More >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Approves First New Sunscreen Ingredient in 20 Years
    • Allergan Aesthetics Releases ‘The Aesthetics Evolution: What Consumers Really Want’ Highlighting Consumer Motivations and Expectations in Aesthetics
    • Moxie Announces Treatment Plans
    • Pacific Reliance Medical M&A Advisors Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Misinformation on Hyaluronic Acid (HA) Fillers Taking Over Your Practice? A New Fact-Based Campaign by Allergan Aesthetics Sets the Story Straight